Childhood leukemia is usually caused by genetic changes that arise by chance in developing blood cells, not by anything a parent did or failed to do. A small number of cases are linked to inherited syndromes such as Down syndrome or to high-dose radiation exposure. Treatment has improved dramatically: today most children with the commonest type, acute lymphoblastic leukemia, are cured.
For families facing a diagnosis, the first question is often “why did this happen?” This guide explains the known causes and risk factors, the warning signs, how the diagnosis is made, and where treatment is heading.
What Is Childhood Leukemia?
Childhood leukemia is a cancer of the blood-forming cells in the bone marrow. Immature cells called blasts multiply out of control and crowd out normal production of red cells, platelets, and infection-fighting white blood cells. It is the most common cancer in children.
There are several types of childhood leukemia, which differ in the cell they start from and how they are treated.
| Type | Share of childhood cases | Key features |
|---|---|---|
| Acute lymphoblastic leukemia (ALL) | About three-quarters | Peaks between ages 2 and 5; most arise from B-cells |
| Acute myeloid leukemia (AML) | Most of the remainder | More common in infants and teenagers; more intensive treatment |
| Chronic myeloid leukemia (CML) | Rare | Driven by the BCR-ABL1 fusion; treated with oral targeted drugs |
| Juvenile myelomonocytic leukemia (JMML) | Very rare | Seen in young children; linked to certain genetic syndromes |
What Causes Childhood Leukemia?
In most children, no single cause is ever found. Leukemia develops when acquired mutations accumulate in a blood stem cell or its descendants. These changes happen inside the cell during development and are generally not inherited from parents or passed on to siblings.
Genetic changes in the leukemia cells
Some changes are well described. The ETV6-RUNX1 fusion (formerly called TEL-AML1) is one of the most common in B-cell ALL, and extra chromosomes, called hyperdiploidy, are also frequent. Rearrangements of the KMT2A gene (formerly MLL) are typical of leukemia in infants.
Research on newborn blood samples suggests that some of these changes are present before birth. A second “hit” after birth appears to be needed for leukemia to develop, which is why most children carrying an early change never become ill.
The infection hypothesis
One leading theory proposes that children with less exposure to common infections in early life may have an immune system that later overreacts to ordinary infections. In a child already carrying a pre-leukemic change, that response could provide the second hit. The idea is plausible but not proven, and it does not mean parents should avoid hygiene or vaccines.
Risk Factors
A risk factor raises the chance of disease but does not mean a child will get it. Most children with leukemia have none of these.
- Down syndrome: children with Down syndrome have a markedly higher risk of both ALL and AML.
- Other inherited conditions: Li-Fraumeni syndrome, neurofibromatosis type 1, Fanconi anemia, Bloom syndrome, and ataxia-telangiectasia.
- A sibling with leukemia: risk is higher, especially for an identical twin.
- High-dose ionizing radiation: such as prior radiation therapy or nuclear accidents. Routine X-rays carry very little risk.
- Previous chemotherapy: certain drugs used for other cancers can cause a later leukemia.
- Immune suppression: for example after an organ transplant.
Links to parental smoking, some household chemicals, and pesticides have been suggested, but the evidence is weaker and less consistent. Things that are not causes include diet, minor injuries, and power lines at normal exposure levels.
Signs and Symptoms
Symptoms come from the loss of normal blood cells and the build-up of leukemia cells. They often develop over a few weeks and can be mistaken for common childhood illnesses.
- Tiredness and pale skin from anemia
- Frequent or prolonged infections and fevers
- Easy bruising, nosebleeds, and pinpoint red spots (petechiae) from low platelets
- Bone or joint pain, sometimes causing a limp or refusal to walk
- Swollen lymph nodes, belly swelling from an enlarged liver or spleen
- Loss of appetite and weight loss
How Childhood Leukemia Is Diagnosed
A complete blood count is usually the first test; it often shows low red cells or platelets, abnormal white cell counts, and blasts on the blood smear. The diagnosis is confirmed by a bone marrow aspiration and biopsy, usually taken from the hip under sedation.
Specialists examine the marrow cells with flow cytometry, cytogenetics, and molecular tests to identify the exact subtype and genetic changes. A lumbar puncture checks whether leukemia has reached the fluid around the brain and spinal cord. Together these results set the child’s risk group, which guides treatment intensity. Background on how bone marrow works can help families follow these discussions.
Treatment and Recent Advances
Childhood leukemia treatment is tailored to the type and risk group. For ALL, chemotherapy is given in phases:
- Induction: about a month of treatment aiming for remission.
- Consolidation and intensification: further treatment to clear remaining cells, including therapy directed at the central nervous system.
- Maintenance: lower-intensity, mostly oral treatment, with total therapy lasting around two to three years.
AML treatment is shorter but more intensive, and a stem cell transplant may be recommended for higher-risk disease. The details differ by subtype; for example, see our article on B-cell ALL survival rates and treatment.
What has changed recently
- Minimal residual disease (MRD) testing: highly sensitive tests detect tiny numbers of leftover leukemia cells, letting doctors intensify or reduce treatment.
- Targeted drugs: tyrosine kinase inhibitors for Philadelphia chromosome-positive ALL and CML.
- Immunotherapy: blinatumomab, an antibody that links T-cells to leukemia cells, and CAR T-cell therapy, which reprograms a child’s own T-cells, now offer options for relapsed or resistant B-cell ALL.
- Better supportive care: improved infection prevention and transfusion support have made intensive treatment safer.
Gene-editing approaches are being studied but remain experimental. For a wider view of adult and pediatric options, see leukemia treatment strategies from diagnosis onward, or our leukemia guide.
Key Takeaways
- Most childhood leukemia results from random genetic changes; parents are not to blame.
- Known risk factors include Down syndrome, some inherited syndromes, and high-dose radiation.
- Persistent tiredness, bruising, bone pain, and repeated fevers warrant a blood test.
- Most children with ALL are cured, and immunotherapy has expanded options after relapse.
As a hematological condition, childhood leukemia is best managed at a specialist pediatric cancer center.
Frequently Asked Questions
Could I have prevented my child’s leukemia?
Almost certainly not. The genetic changes that cause most cases happen by chance, often before birth, and there is no known lifestyle step that prevents them.
Is childhood leukemia hereditary?
Usually not. Only a small minority of cases involve an inherited syndrome. Siblings have a somewhat higher risk, but most never develop leukemia.
What is the survival rate for childhood leukemia?
For ALL, roughly 9 in 10 children are now long-term survivors. AML outcomes are lower but have improved steadily. Your child’s team can explain what their specific risk group means.
How long does treatment last?
ALL treatment typically lasts about two to three years, most of it as outpatient maintenance. AML treatment is usually completed within several months.
